Trial Profile
Safety and efficacy of G17DT Immunogen [gastrin-17 vaccine] in the treatment of gastric and gastroesophageal cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2005
Price :
$35
*
At a glance
- Drugs Polyclonal antibody stimulator (Primary) ; Antineoplastics
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 18 Sep 2005 New trial record.